RE: 5-year, 7-figure collaboration for GENinCode Plc16 Feb 2026 13:57
From the funding Rns
CVD is the leading cause of death worldwide, responsible for over 17.9 million deaths annually, which equates to approximately 31% of all global deaths (World Health Organisation). With the global annual cost of CVD projected to surpass $1.04 trillion by 2030, the directors believe there is an unmet need to accelerate the adoption of genetic testing as an adjunct to the current standard of care. The directors believe GENinCode's proprietary solutions address this unmet need by integrating genetic and clinical data to improve risk prediction, risk assessment, and personalised treatment pathways for CVD and related conditions.